Accession Number: | 0001387131-20-010306 |
Date: | 2020-11-24 |
Issuer: | THERAPEUTICSMD, INC. (TXMD) |
Original Submission Date: |
MILLIGAN JOHN C.K. IV
951 YAMATO ROAD, SUITE 220
BOCA RATON, FL 33431
Title of Security | Transaction Date | 2a. Deemed Execution Date | Transaction Code | Shares | Acquired or Disposed | Price per share | 5. Amount of Securities Beneficially Owned Following Reported Transaction | 6. Ownership Form Direct or Indirect | Nature of Indirect Ownership |
---|
Title of Derivative Security | Conversion or Exercise Price of Derivative Security | Transaction Date | Deemed Execution Date | Transaction Code | Number of Derivative Securities Acquired (A) or Disposed of (D) | Date Exercisable | Expiration Date | Title and Amount of Securities Underlying Derivative Security | Price of Derivative Security | Number of derivative Securities Beneficially Owned Following Reported Transaction(s) | Ownership Form: Direct (D) or Indirect (I) | Nature of Indirect Beneficial Ownership |
---|---|---|---|---|---|---|---|---|---|---|---|---|
RESTRICTED STOCK UNITS | 0.0 | 2020-11-24 | deemed execution date | A | 360,000 (a) | common stock 360,000 | $0.00 | 360,000 | direct |
ID | footnote |
---|---|
f1 | each restricted stock unit (rsu) represents a contingent right to receive one share of common stock of the issuer. the rsus will vest in two equal installments on november 24, 2021 and november 24, 2022. |